B cells in SLE exhibit multiple abnormalities, including increased expression of co-stimulatory molecules (CD40, CD80), increased survival signaling through the B cell-activating factor (BAFF), and resistance to apoptosis [22,23,24]. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.